恶名声
发表于 2025-3-25 04:50:56
http://reply.papertrans.cn/59/5891/589004/589004_21.png
CURB
发表于 2025-3-25 10:10:56
Barbara Mauthe,Thomas E. Webbgether, this book condenses, consolidates, compares, and contrasts data derived from the human and mouse LS experiences and provides a unique resource for clinical and basic scientists to evaluate and compare IGF-I and GH actions.978-3-662-50171-9978-3-642-11183-9
HUSH
发表于 2025-3-25 14:43:24
Chris Thornhillgether, this book condenses, consolidates, compares, and contrasts data derived from the human and mouse LS experiences and provides a unique resource for clinical and basic scientists to evaluate and compare IGF-I and GH actions.978-3-662-50171-9978-3-642-11183-9
GLOOM
发表于 2025-3-25 17:58:33
http://reply.papertrans.cn/59/5891/589004/589004_24.png
placebo
发表于 2025-3-25 22:41:37
http://reply.papertrans.cn/59/5891/589004/589004_25.png
悲痛
发表于 2025-3-26 00:25:07
http://reply.papertrans.cn/59/5891/589004/589004_26.png
invert
发表于 2025-3-26 05:01:17
Luhmann, All Too Luhmann: Nietzsche, Luhmann and the Human traditions.. This constitutes a 180-degree change in perspective in how one may understand the social world. For Luhmann, society is sometimes fair, sometimes unfair, but always imbued with clear, relatively easy-to-understand operational guidelines if one observes with an adequate systematic framework.
横条
发表于 2025-3-26 08:51:02
The Autopoietic Fold: Critical Autopoiesis between Luhmann and Deleuzeeir own folds and deepen their immanence. To fold is nothing more than to push the theory deeper into its creative potential while at the same time bringing it to an encounter with a radical outside. The theory confronting the theory.
粗鲁的人
发表于 2025-3-26 14:57:41
In the Multiverse What Is Real? Luhmann, Complexity and ANTd equally legitimate understanding of society and that the notion of society can accommodate multiple realities. In other words, society can be represented as a multiverse and not a single unique universe.
密切关系
发表于 2025-3-26 19:07:22
Only Connect: Luhmann and Bioethicstion to ensure that it is a donor-compatible tissue match. It is the first, and so far the only, instance of the ‘screening in’ of desirable genetic characteristics allowed within the UK regulatory framework.